Allogeneic stem cell transplantation reduces the relapse incidence in patients with AML and normal karyotype independently of the FLT3-ITD status

被引：0
|
作者：
Schueller, F.
Maschmeyer, G.
Fischer, T.
Herold, M.
Sayer, H. G.
Wolf, H. -H.
Kreibich, U.
Haehling, D.
Doelken, G.
Junghanss, C.
Grobe, N.
Krahl, R.
Lange, T.
Al Ali, H. -K.
Basara, N.
Poenisch, W.
Niederwieser, D.
机构：
来源：
BONE MARROW TRANSPLANTATION | 2010年 / 45卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S39 / S40
页数：2
相关论文
共 50 条
  • [31] FLT3-ITD Mutation and Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia: A Case Study
    Saeed, Shahzeb
    Nagaraj, Raghu Halappa
    Grezenko, Han
    Rehman, Abdur
    Shehryar, Abdullah
    Anwaar, Mohammad Ahsan
    Lazarevic, Slobodan
    Shahzed, S. M. Iram
    Das, Archana
    Vargas, Karla I.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (07)
  • [32] Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remission
    Feng-Ming Tien
    Cheng-Hong Tsai
    Sheng-Chuan Huang
    Jia-Hau Liu
    Chien-Yuan Chen
    Yuan-Yeh Kuo
    Yi-Kuang Chuang
    Mei-Hsuan Tseng
    Yen-Ling Peng
    Ming-Chih Liu
    Chia-Wen Liu
    Xiu-Wen Liao
    Liang-In Lin
    Yu-Sin Wu
    Mei-Fang Hou
    Shang-Ju Wu
    Szu-Chun Hsu
    Bor-Sheng Ko
    Wen-Chien Chou
    Ming Yao
    Hsin-An Hou
    Jih-Luh Tang
    Hwei-Fang Tien
    Bone Marrow Transplantation, 2022, 57 : 95 - 105
  • [33] Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remission
    Tien, Feng-Ming
    Tsai, Cheng-Hong
    Huang, Sheng-Chuan
    Liu, Jia-Hau
    Chen, Chien-Yuan
    Kuo, Yuan-Yeh
    Chuang, Yi-Kuang
    Tseng, Mei-Hsuan
    Peng, Yen-Ling
    Liu, Ming-Chih
    Liu, Chia-Wen
    Liao, Xiu-Wen
    Lin, Liang-In
    Wu, Yu-Sin
    Hou, Mei-Fang
    Wu, Shang-Ju
    Hsu, Szu-Chun
    Ko, Bor-Sheng
    Chou, Wen-Chien
    Yao, Ming
    Hou, Hsin-An
    Tang, Jih-Luh
    Tien, Hwei-Fang
    BONE MARROW TRANSPLANTATION, 2022, 57 (01) : 95 - 105
  • [34] Clinical implications of the FLT3-ITD allelic ratio (AR) in acute myeloid leukemia (AML) in the context of an allogeneic stem cell transplantation (HSCT)
    Jentzsch, M.
    Kuepper, J.
    Bill, M.
    Grimm, J.
    Brauer, D.
    Backhaus, D.
    Schulz, J.
    Franke, G. N.
    Vucinic, V.
    Niederwieser, D.
    Platzbecker, U.
    Schwind, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 135 - 137
  • [35] Allogeneic Hematopoietic Cell Transplantation in AML with Normal Karyotype and NPM1 Mutated FLT3-ITD Negative: A Retrospective Analysis from the Acute Leukemia Working Party of EBMT
    Bazarbachi, Ali
    Labopin, Myriam
    Kharfan-Dabaja, Mohamed A.
    Schwerdtfeger, Rainer
    Volin, Liisa
    Bourhis, Jean-Henri
    Socie, Gerard
    Deconinck, Eric
    Gedde-Dahl, Tobias
    Rambaldi, Alessandro
    Jindra, Pavel
    Schlimok, Guenter
    Blaise, Didier
    Chevallier, Patrice
    Nagler, Arnon
    Schmid, Christoph
    Esteve, Jordi
    Mohty, Mohamad
    BLOOD, 2014, 124 (21)
  • [36] Treatment of FLT3-ITD Positive AML Relapsing After Allogeneic Hematopoietic Stem Cell Transplant (HSCT) with Sorafenib
    Sharma, Manish R.
    Ravandi, Farhad
    Chiattone, Alexandre
    Kebriaei, Partow
    Popat, Uday
    Giralt, Sergio
    Bashir, Qaiser
    Qazilbash, Muzaffar H.
    Nieto, Yago
    Yuen, Carrie Hai-Lai
    Parmar, Simrit
    Kantarjian, Hagop M.
    Cortes, Jorge
    Kadia, Tapan
    Borthakur, Gautam
    Champlin, Richard E.
    De Lima, Marcos
    BLOOD, 2010, 116 (21) : 1426 - 1426
  • [37] Successful treatment with gilteritinib for isolated extramedullary relapse of acute myeloid leukemia with FLT3-ITD mutation after allogeneic stem cell transplantation
    Kida, Michiko
    Kuroda, Yoshiaki
    Kido, Miki
    Chishaki, Ren
    Kuraoka, Kazuya
    Ito, Takuo
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2020, 112 (02) : 243 - 248
  • [38] Successful treatment with gilteritinib for isolated extramedullary relapse of acute myeloid leukemia with FLT3-ITD mutation after allogeneic stem cell transplantation
    Michiko Kida
    Yoshiaki Kuroda
    Miki Kido
    Ren Chishaki
    Kazuya Kuraoka
    Takuo Ito
    International Journal of Hematology, 2020, 112 : 243 - 248
  • [39] Maintenance sorafenib in FLT3-ITD AML following allogeneic HCT favorably impacts relapse and overall survival
    Grant Chappell
    Marcus Geer
    Erin Gatza
    Thomas Braun
    Tracey Churay
    Joseph Brisson
    Dale Bixby
    Bernard Marini
    Anthony Perissinotti
    David Frame
    Brian Parkin
    Pavan Reddy
    John Magenau
    Sung Won Choi
    Bone Marrow Transplantation, 2019, 54 : 1518 - 1520
  • [40] Prophylaxis DLI alone may not prevent relapse of FLT3-ITD positive AML after allogeneic HCT
    Cao, LiQin
    Shi, JiMin
    Zhao, YanMin
    Luo, Yi
    Yu, Jian
    Tan, Ya-Min
    Lai, Xiao-Yu
    Zhu, Yuan-Yuan
    Wei, Guo-Qing
    Sun, Jie
    He, Jing-Song
    Zheng, Wei-Yan
    Cai, Zhen
    Huang, He
    BONE MARROW TRANSPLANTATION, 2019, 54 : 169 - 169
12345